Stock data
Solid Biosciences Inc. (SLDB)
Solid Biosciences Inc. (SLDB) reported net income of -US$174.32M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$179.21M | -US$174.32M | — |
| 2024 | — | — | -US$129.73M | -US$124.70M | — |
| 2023 | — | — | -US$104.25M | -US$96.02M | — |
| 2022 | US$8.09M | — | -US$106.45M | -US$85.98M | — |
| 2021 | US$13.62M | — | -US$72.25M | -US$72.19M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$54.80M | — |
| 2026-03-31 | — | -US$56.74M | — |
| 2025-12-31 | — | -US$49.79M | — |
| 2025-09-30 | — | -US$45.78M | — |
| 2025-06-30 | — | -US$39.48M | — |
| 2025-03-31 | — | -US$39.28M | — |
| 2024-12-31 | — | -US$42.60M | — |
| 2024-09-30 | — | -US$32.73M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.